Study detail
RecruitingPhase 4
Novel Serotype Alert: Investigate New Pneumococcal Conjugate Vaccines for Inducing Cross-protection Against Newly Discovered Serotype 33E and Putative Novel Serogroup 33 Serotypes
University of Alabama at Birmingham
Summary
The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend against certain types of bacteria. We will give two different types of vaccine and evaluate the effectiveness of antibodies produced by each vaccine in killing bacteria.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
Detailed criteria
Inclusion Criteria: * Healthy adult Exclusion Criteria: * No prior history of pneumococcal vaccination * No immunosuppressing medications or chronic diseases that affect immune function
Interventions
- BiologicalPneumococcal Vaccine
PCV
Location
- University of Alabama at BirminghamBirmingham, Alabama